Aldar S. Bourinbaiar
Immunitor USA Inc.
Aldar S. Bourinbaiar is CEO of Immunitor USA Inc., manufacturer and developer of oral vaccines. He received M.Sc. in Zoology/BioStatistics from National University of Mongolia, UlanBator, Mongolia. Trained in Computer Programming/Statistics, Jan Comenius University, Bratislava, Czechoslovakia, M.Sc. D.E.A. in Population Genetics Epidemiological Anthropology, University of Paris VII, Ph.D. 3eme cycle in Cancer Immunogenetics Cytogenetics, University of Paris VII, M.D./Ph.D. D.E.R.B.H. in Experimental Oncology, Transplantation and Cancer Immunology, KremlinBicetre Medical School, University of Paris XI, M.A. in Mongolian History and Civilization, Sorbonne Nouvelle, University of Paris III, Paris, France, B.A. in Russian Literature and Language, Sorbonne Nouvelle, University of Paris III, Paris, France. Fluent in Mongolian, Russian, French and English. Basic knowledge of Japanese, Slovak, and Thai. Fellow of Claude Bernard Association, Paris, France. Fellowship award from NATO Institute for Advanced Studies. Award of excellence in research by Hayashibara Biochemical Co., Japan. Published over 130 publications and 5 books. Six awarded US patents on antiviral and anticancer drugs. He is serving on editorial board of three peer reviewed journals. Elected as Thailands regional representative by International Organization on Biotechnology and Bioengineering, Stockholm, Sweden. Expert member of the Society of Industry Leaders, a division of Standard Poors, New York. NIH grant reviewer on AIDS related projects for 20052006 cycle. Listed in International Who is Who Professionals, Marquis Whos Who, Marquis Whos Who in Asia, Who is Who Historical Society, Cambridges 2000 Outstanding Intellectuals of 21st Century.
Immunophenotyping and cytohistochemistry. Flow cytometry and cell sorting. Fluorescence and electron microscopy. ELISA and radioimmunoprecipitation (RIPA) assays. Monoclonal antibody preparation and biotin labeling. Antibody-antigen interaction. Vaccine development. Immunoglobulin isotyping. CTL and MLR assays. Apoptosis. CTL cloning and limiting dilution assays. Cell adhesion assays. Characterization and culture of primary and established tumor cell lines. Inflammatory mediators. Leukocyte enzymes, cytokines, interferons, growth factors, neurotransmitters, and hormone assays. Reproductive physiology and endocrinology. Semen and sperm analysis. Signal transduction. Transmembrane transport. Endocytosis and phagocytosis. Preparation and extraction of DNA, RNA, and mRNA. Hirt extraction. Recombinant DNA methodology. Cloning and gene expression. Rabbit reticulocyte transcription/translation assay. CAT assay. Quantitative PCR and RT-PCR. Southern and Northern blot and gel analysis. Chromosome preparation and karyotyping. Isotopic and non-isotopic in situ hybridization and detection. Agarose and PAGE electrophoresis and Western blot. Protein purification, chromatography, chemistry and crystallization. Receptor binding and ligand radiolabeling. Functional and quantitative protease assays and identification. Topoisomerase assay. General microbiology and bacteriology. Methods for growth, isolation, purification, detection and quantitation of HIV, HTLV, and herpesviruses. Reverse transcriptase and integrase assays. In vitro assays for antiviral drugs and vaccines. Computer and statistical analysis of data related to clinical trials. Clinical trials organization. Grant writing and soliciting from public and private foundations. Extensive database search experience for gene and amino acid sequences.